<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03502941</url>
  </required_header>
  <id_info>
    <org_study_id>217658</org_study_id>
    <nct_id>NCT03502941</nct_id>
  </id_info>
  <brief_title>Effect of an EAA/Whey Composition on Protein Metabolism</brief_title>
  <official_title>Effect of an Essential Amino Acid/Protein Composition on Protein Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia, a progressive loss of muscle mass, strength and function, is an inevitable&#xD;
      natural process of aging. While it may be impossible to completely reverse the progress of&#xD;
      sarcopenia, it is well established that intake of dietary protein through essential amino&#xD;
      acids (EAAs) and whey protein increases anabolic response. The current study will test if a&#xD;
      specially formulated mixture of EAAs and whey protein can maximally stimulate anabolic&#xD;
      responses at the levels of whole body and muscle compared to whey protein alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The product composition is protected by intellectual property. It contains a combination of&#xD;
      ingredients designed to stimulate anabolic responses at whole body and muscle and to&#xD;
      ultimately induce long-term improvements in muscle function and size. EAAs are the only&#xD;
      dietary macronutrients that are required for survival. They are &quot;essential&quot; because the body&#xD;
      cannot produce them. There are 9 dietary EAAs while there are 11 dietary non-essential amino&#xD;
      acids that are not required in the diet because they can be produced in the body. The&#xD;
      composition is based on a blend of 8 of the 9 EAAs. In addition to being the &quot;active&quot;&#xD;
      components of dietary protein, EAAs also have the advantage over intact protein including&#xD;
      whey protein because free EAAs are absorbed from the intestine more quickly and more&#xD;
      completely than amino acids contained in protein, which requires digestion before absorption&#xD;
      indicating that intact protein is relatively slowly absorbed. Therefore, the combination of&#xD;
      free EAAs and intact protein give not only an immediate response (from the free EAAs) but&#xD;
      also a prolonged response (from the intact protein) over time by the slower digestion. The&#xD;
      idea of combining a specific formulation of EAAs with an intact protein to obtain both an&#xD;
      immediate as well as a more sustained response in protein anabolism is novel. Investigators&#xD;
      propose that consumption of the EAA/protein composition will stimulate the net protein&#xD;
      balance at the whole body level in a dose-dependent manner. The investigators further propose&#xD;
      that the magnitude of increase in the net protein balance will be greater than induced by the&#xD;
      consumption of the same amount of whey protein isolate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 20, 2018</start_date>
  <completion_date type="Actual">July 17, 2019</completion_date>
  <primary_completion_date type="Actual">April 9, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Arm 1 and 2: Crossover design for two different doses of the product (~6.3 and 12.6 g of active components).&#xD;
Arm 3: Parallel comparison equal to the double dose of whey protein isolate (12.6 g)</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Protein Anabolism</measure>
    <time_frame>Change from 4.5 to 8.5 hours.</time_frame>
    <description>Changes in net protein balance at whole body (grams)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protein Synthesis</measure>
    <time_frame>From 4.5 to 8.5 hours.</time_frame>
    <description>Changes in protein synthesis in muscle (percent)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>A single dose of EAAs/whey</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 6.3 g of EAAs/whey in ~12 oz water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A double dose of EAAs/whey</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 12.6 g of EAAs/whey in ~12 oz water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whey protein alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 12.6 g of whey protein isolate which is an equal amount to the double dose of EAAs/whey.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>6.3 g of EAAs mixture and whey protein isolate</intervention_name>
    <description>A single dose of the mixture of EAAs/whey</description>
    <arm_group_label>A single dose of EAAs/whey</arm_group_label>
    <other_name>Essential Blends, Fairbanks, Alaska (AK), and Pure Protein, Bayport, New York (NY)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>12.6 g of EAAs mixture and whey protein isolate</intervention_name>
    <description>A double dose of the mixture of EAAs/whey</description>
    <arm_group_label>A double dose of EAAs/whey</arm_group_label>
    <other_name>Essential Blends, Fairbanks, AK, and Pure Protein, Bayport, NY</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>12.6 g of whey protein isolate</intervention_name>
    <description>Whey protein isolate alone, which is an equal amount to the double dose of the mixture of EAAs/whey</description>
    <arm_group_label>Whey protein alone</arm_group_label>
    <other_name>Pure Protein, Bayport, NY</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI between 20 and 30 kg/m^2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current diagnosis of diabetes&#xD;
&#xD;
          -  History of malignancy in the 6 months prior to enrollment&#xD;
&#xD;
          -  Weight reduction surgery&#xD;
&#xD;
          -  Chronic inflammatory (Lupus, HIV/AIDS)&#xD;
&#xD;
          -  Currently pregnant females&#xD;
&#xD;
          -  Unable to eat dairy protein&#xD;
&#xD;
          -  Unable to stop eating protein or Amino Acid (AA) supplements during the participation&#xD;
&#xD;
          -  Regular resistance training (&gt; once per week)&#xD;
&#xD;
          -  Concomitant use of corticosteroids (ingestion, injection or transdermal)&#xD;
&#xD;
          -  Subjects who cannot safely stop using aspirin for 7 days prior to muscle biopsies&#xD;
&#xD;
          -  Hemoglobin less than 9.5 g/dL, and platelets less than 150,000 at the screening visit&#xD;
&#xD;
          -  Any other disease or condition placing the subject at increased risk of harm if they&#xD;
             were to participate, at the discretion of the study physician&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arny A Ferrando, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 30, 2018</study_first_submitted>
  <study_first_submitted_qc>April 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2018</study_first_posted>
  <results_first_submitted>September 1, 2021</results_first_submitted>
  <results_first_submitted_qc>November 1, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">November 2, 2021</results_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT03502941/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of the 16 subjects enrolled, 8 were randomized into an arm that has a crossover component of two study interventions. The other 8 subjects were randomized into a control arm that had only one intervention.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>EAAs/Whey (6.3 g Dose First, Then 12.6g)</title>
          <description>Subjects will consume 6.3 g of EAAs/whey in ~12 oz water at their first intervention visit, then 12.6 g of the same product at their second intervention visit.</description>
        </group>
        <group group_id="P2">
          <title>EAAs/Whey (12.6g First, Then 6.3g)</title>
          <description>Subjects will consume 12.6 g of EAAs/whey in ~12 oz water at their first intervention visit, then 6.3 g of the same product at their second intervention visit.</description>
        </group>
        <group group_id="P3">
          <title>Whey Protein Alone</title>
          <description>Subjects will consume 12.6 g of whey protein isolate which is an equal amount to the double dose of EAAs/whey.&#xD;
12.6 g of whey protein isolate: Whey protein isolate alone, which is an equal amount to the double dose of the mixture of EAAs/whey</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>EAAs/Whey: 6.3g First, Then 12.6g</title>
          <description>Subjects will consume 6.3 g of EAAs/whey in ~12 oz water on 1 day. Then washout at least 5 days. Then consume 12.6 g of study product at another visit.</description>
        </group>
        <group group_id="B2">
          <title>EAAs/Whey: 12.6g First, Then 6.3g</title>
          <description>Subjects will consume 12.6 g of EAAs/whey in ~12 oz water on 1 day. Then washout at least 5 days. Then consume 6.3 g of study product at another visit.</description>
        </group>
        <group group_id="B3">
          <title>Whey Protein Alone</title>
          <description>Subjects will consume 12.6 g of whey protein isolate which is an equal amount to the double dose of EAAs/whey.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="8"/>
            <count group_id="B4" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Protein Anabolism</title>
        <description>Changes in net protein balance at whole body (grams)</description>
        <time_frame>Change from 4.5 to 8.5 hours.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>A Single Dose of EAAs/Whey</title>
            <description>Subjects will consume 6.3 g of EAAs/whey in ~12 oz water.&#xD;
6.3 g of EAAs mixture and whey protein isolate: A single dose of the mixture of EAAs/whey</description>
          </group>
          <group group_id="O2">
            <title>A Double Dose of EAAs/Whey</title>
            <description>Subjects will consume 12.6 g of EAAs/whey in ~12 oz water&#xD;
12.6 g of EAAs mixture and whey protein isolate: A double dose of the mixture of EAAs/whey</description>
          </group>
          <group group_id="O3">
            <title>Whey Protein Alone</title>
            <description>Subjects will consume 12.6 g of whey protein isolate which is an equal amount to the double dose of EAAs/whey.&#xD;
12.6 g of whey protein isolate: Whey protein isolate alone, which is an equal amount to the double dose of the mixture of EAAs/whey</description>
          </group>
        </group_list>
        <measure>
          <title>Protein Anabolism</title>
          <description>Changes in net protein balance at whole body (grams)</description>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.56" spread="1.89"/>
                    <measurement group_id="O2" value="11.8" spread="1.79"/>
                    <measurement group_id="O3" value="3.02" spread="0.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>P value was calculated.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Protein Synthesis</title>
        <description>Changes in protein synthesis in muscle (percent)</description>
        <time_frame>From 4.5 to 8.5 hours.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>A Single Dose of EAAs/Whey</title>
            <description>Subjects will consume 6.3 g of EAAs/whey in ~12 oz water.&#xD;
6.3 g of EAAs mixture and whey protein isolate: A single dose of the mixture of EAAs/whey</description>
          </group>
          <group group_id="O2">
            <title>A Double Dose of EAAs/Whey</title>
            <description>Subjects will consume 12.6 g of EAAs/whey in ~12 oz water&#xD;
12.6 g of EAAs mixture and whey protein isolate: A double dose of the mixture of EAAs/whey</description>
          </group>
          <group group_id="O3">
            <title>Whey Protein Alone</title>
            <description>Subjects will consume 12.6 g of whey protein isolate which is an equal amount to the double dose of EAAs/whey.&#xD;
12.6 g of whey protein isolate: Whey protein isolate alone, which is an equal amount to the double dose of the mixture of EAAs/whey</description>
          </group>
        </group_list>
        <measure>
          <title>Protein Synthesis</title>
          <description>Changes in protein synthesis in muscle (percent)</description>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.024" spread="0.048"/>
                    <measurement group_id="O2" value="0.044" spread="0.038"/>
                    <measurement group_id="O3" value="0.022" spread="0.041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment to last study visit, an average of 1 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>A Single Dose of EAAs/Whey</title>
          <description>Subjects will consume 6.3 g of EAAs/whey in ~12 oz water.&#xD;
6.3 g of EAAs mixture and whey protein isolate: A single dose of the mixture of EAAs/whey</description>
        </group>
        <group group_id="E2">
          <title>A Double Dose of EAAs/Whey</title>
          <description>Subjects will consume 12.6 g of EAAs/whey in ~12 oz water&#xD;
12.6 g of EAAs mixture and whey protein isolate: A double dose of the mixture of EAAs/whey</description>
        </group>
        <group group_id="E3">
          <title>Whey Protein Alone</title>
          <description>Subjects will consume 12.6 g of whey protein isolate which is an equal amount to the double dose of EAAs/whey.&#xD;
12.6 g of whey protein isolate: Whey protein isolate alone, which is an equal amount to the double dose of the mixture of EAAs/whey</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David D.Church, Ph.D.</name_or_title>
      <organization>University of Arkansas for Medical Sciences</organization>
      <phone>5015265709</phone>
      <email>dchurch@uams.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

